Single and Multiple Ascending Oral Dose Study of RX-10001 in Healthy Volunteers

NCT00941018 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
56
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Resolvyx Pharmaceuticals, Inc